SEC Form 4/A · accession 0001209191-18-055419
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
William D Baird III
Officer — Chief Financial Officer
Period of report
Jul 2, 2018
Accepted (ET)
Oct 17, 2018 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2018 | M | 10,000 | $2.45 | A | 127,622 | D | |
| Common StockF3,F1 | Jul 2, 2018 | S | 10,000 | $15.6292 | D | 117,622 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 amendment corrects the reporting person's amount of securities beneficially owned following the reported transaction.
- F2The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.
- F3This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.45 to $15.91. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.